UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046405
Receipt number R000052910
Scientific Title Single center retrospective observational study of telemedicine in prescribing LEP (low dose pills) for dysmenorrhea patients
Date of disclosure of the study information 2021/12/21
Last modified on 2024/01/31 23:59:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of telemedicine in prescribing low dose pills for dysmenorrhea patients

Acronym

Study of telemedicine in prescribing low dose pills

Scientific Title

Single center retrospective observational study of telemedicine in prescribing LEP (low dose pills) for dysmenorrhea patients

Scientific Title:Acronym

Single center retrospective observational study of telemedicine in prescribing LEP for dysmenorrhea patients

Region

Japan


Condition

Condition

dysmenorrhea

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirm that using telemedicine when prescribing LEP does not increase disadvantage compared to using only face to face medical treatment.

Basic objectives2

Others

Basic objectives -Others

Investigation of Medical treatment form

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Probability of abnormal uterine bleeding in 6 months after the start of treatment

Key secondary outcomes

Other side effects
Continuation rate for treatment
Cost burden of patient
Treatment effectivity


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

Common to Both Group
1)Patients with dysmenorrhea whose target period includes the start of LEP and 6 months after the start

Telemedicine Group
1)Patients who have had at least one telemedicine within 6 months after the start of LEP

In-person care Group
1)Patients who have never had telemedicine and only have had in-person care within 6 months after the start of LEP

Key exclusion criteria

Common to Both Group
1)Patients who reject to be included this study
2)One or more LEP prescription contraindications are applicable at the start of prescription

In-person care Group
1)Patients who start LEP prescription after the telemedicine system introduction

Target sample size

212


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Iida

Organization

Yokohama City University School of Medicine

Division name

Department of Medial Education

Zip code

236-0004

Address

3-9, Fukuura, Kanazawa-ku, Kanagawa

TEL

045-787-2627

Email

hiro0905@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Yumi
Middle name
Last name Inoo

Organization

Yokohama City University School of Medicine

Division name

Department of Medial Education

Zip code

236-0004

Address

3-9, Fukuura, Kanazawa-ku, Kanagawa

TEL

045-787-2627

Homepage URL


Email

inoo.yum.dk@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University School of Medicine Department of Medical Education

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

of Yokohama City University Life Science and Medical Research Ethics Committee for Humans

Address

236-0004 3-9, Fukuura, Kanazawa-ku, Kanagawa

Tel

045-370-7627

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

【既存試料・情報の提供のみを行う機関】
・医療法人社団 昱樹会 磯子悠レディースクリニック
・医療法人社団 都筑会 つづきレディスクリニック


Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

172

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 10 Month 27 Day

Date of IRB

2021 Year 12 Month 08 Day

Anticipated trial start date

2021 Year 12 Month 24 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A retrospective non-inferiority observational study of a group that combines telemedicine and in-person care with respect to a group that uses only in-person care.


Management information

Registered date

2021 Year 12 Month 17 Day

Last modified on

2024 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052910